Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor
NCT02016170
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
82
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease
Acute Coronary Syndrome
Interventions
DRUG:
Ticagrelor 180mg
DRUG:
Prasugrel 10mg
DRUG:
Ticagrelor 90mg
Sponsor
University of Florida